Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Oncorus, Inc. (ONCR) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/07/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/03/2023 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
08/03/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/03/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
07/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
07/28/2023 8-K Quarterly results
07/19/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/19/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/19/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/19/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/19/2023 RW Form RW - Registration Withdrawal Request:
07/19/2023 8-K Quarterly results
07/10/2023 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
06/16/2023 3 Shea Brian J. (Interim CEO) has filed a Form 3 on Oncorus, Inc.
06/12/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
06/09/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
06/07/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Approval of Plan. The Board of Directors of the Company has adopted this Plan and presented the Plan to the Company’s stockholders to take action on the Plan. If the Plan is adopted by the requisite vote of the Company’s stockholders, the Plan shall constitute the adopted Plan of the Company. 2. Certificate of Dissolution. Subject to Section 14 hereof, after the stockholders of the Company approve the dissolution of the Company, the Company shall file with the Secretary of State of the State of Delaware a certificate of dissolution in accordance with the DGCL at such time as determined by the Company in its sole discretion . 3. Cessation of Business Activities. After the Effective Time, the Company shall not engage in any business activities except to the extent necessary to preserve the v..."
06/01/2023 8-K Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm...
Docs: "Investor Contact:"
05/18/2023 8-K Termination of a Material Definitive Agreement, Triggering Events That Accelerate or Increase a Direct Financial Obligation o...
05/16/2023 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
05/05/2023 8-K Quarterly results
05/01/2023 10-K/A Annual Report for the period ended December 31, 2022 [amend]
05/01/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/24/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/24/2023 10-K Annual Report for the period ended December 31, 2022
03/24/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Oncorus, Inc. Condensed Consolidated Statements of Operations and Comprehensive Loss Three Months Ended Year Ended December 31, December 31, 2022 2021 2022 2021 Operating expenses: Research and development $ 15,708 $ 14,276 $ 54,744 $ 44,682 General and administrative 5,072 5,586 21,793 20,136 Total operating expenses 20,780 19,862 76,537 64,818 Loss from operations Other income : Other income 285 210 Interest expense — — Interest income 309 27 911 65 Total other income , net 19 56 Net loss $ $ $ $ Comprehensive loss: Net unrealized gain on investments 21 Comprehensive loss $ $ $ $ Net loss per share - basic and diluted $ $ $ $ Weighted-average number of common shares 25,973 25,814 25,924 25,320 Oncorus, Inc. Selected Condensed Consolidated Balance Sheet Data Cash and cash equivalents..."
03/14/2023 8-K Regulation FD Disclosure  Interactive Data
03/10/2023 8-K Regulation FD Disclosure  Interactive Data
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/02/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
12/30/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/30/2022 SC 13D/A Flynn James E reports a 9.8% stake in Oncorus, Inc.
12/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy